Eisai Co. Ltd.

Eisai Co. Ltd.
Stock Exchange Other OTC
EPS
$2
Market Cap
$24.21 B
Shares Outstanding
296.57 M
Public Float
-
Eisai Co. Ltd. ADR
Stock Exchange Other OTC
EPS
$2
Market Cap
$16.36 B
Shares Outstanding
296.57 M
Public Float
-
Eisai Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY221.12
Market Cap
JPY1.78 T
Shares Outstanding
296.57 M
Public Float
237.92 M

Profile

Address
4-6-10 Koishikawa
Tokyo Tokyo 112
Japan
Employees -
Website http://www.eisai.co.jp
Updated 07/08/2019
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs.

Financials

View All

Haruo Naito
Chief Executive Officer & Representative Director
Hirokazu Kanai
Director